Lymphedema Sensor Technology Development Study

Launched by NORTHWESTERN UNIVERSITY · Jan 14, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new type of small, wearable sensors designed to help measure a condition called lymphedema, which is swelling that can occur in the arms, often after cancer treatment. The main goal is to find out if these sensors can accurately detect lymphedema in adults who have been diagnosed with it. If you are an adult aged 18 or older with swelling in one arm and a history of non-metastatic cancer, you might be eligible to participate in this study.

As a participant, you will take part in one in-person session where your lymphedema will be measured using the sensors. About two weeks later, you will receive a phone call from the study team to check on how you are doing. This study is currently looking for participants, and it’s important to note that certain conditions or medical devices, like pacemakers or joint replacements, may prevent you from joining. If you’re interested or want to learn more, the study team can provide additional information.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with a diagnosis of unilateral lymphedema that affects the upper extremity (UE).
• • Patients previously diagnosed with non-metastatic cancer.
• • Adults 18 years of age and older.
• Exclusion Criteria:
• • Patients with history of lymphatic surgery.
• • Patients with implantable devices (e.g., pacemaker, pacemaker/defibrillator, intrathecal pump, joint replacements, etc.) or any other device deemed unsafe by the treating investigator.
• • Patients with an amputation involving the upper extremity.
• • Patients with known allergies to adhesives - including silicone adhesives.
• • Patients with the following comorbidities: diabetes, congestive heart failure, peripheral vascular disease, irradiated upper extremity skin, psoriasis, atopic dermatitis, open wounds/skin breakdown.